Table 1 Patients’ characteristics, clinical course, and outcomes in intensive care unit
Men | 16 (62) |
Age, years | 63 [58–70] |
Body mass index | 25 [23–29] |
Cardiogenic shock etiology | |
Post cardiotomy | 11 (42) |
Acute myocardial infarction | 8 (31) |
Dilated cardiomyopathy | 5 (19) |
0thers | 2 (8) |
Clinical and biological variables at VA-ECLS implantation | |
Resuscitation before VA-ECLS | 9 (35) |
VA-ECLS under CPR | 4 (15) |
SOFA score | 12 [12–13] |
Durable left VAD | 1 (4) |
Transient left VAD | 4 (15) |
IABP | 0 (0) |
Serum lactate, mmol/L | 7.1 [4.5–9.7] |
Prothrombin time, % | 56 [44–64] |
Hemodynamic variables at inclusion (=1st study point) | |
Heart rate, beats/min | 90 [77–100] |
Cardiac pacing | 6 (23) |
Norepinephrine, mg/h | 3 [1.3–5.1] |
Inotropic support | 14 (54) |
Inhaled nitric oxide | 7 (27) |
VA-ECLS flow, L/min | 3.4 [2.9–4.1] |
Left VAD flow if present, L/min | 0.9 [0.4–1.5] |
Clinical course in ICU | |
Days under VA-ECLS | 8 [6–10] |
Add of transient left VAD during VA-ECLS | 4 (15) |
Add of IABP during VA-ECLS | 0 (0) |
Renal replacement therapy | 10 (38) |
Successful VA-ECLS weaning | 18 (69) |
Outcomes | |
Length of ICU stay, days | 21 [13–31] |
ICU survival | 13 (50) |
6-month survival | 11 (42) |